India, China and Other Emerging Markets Key Prospects for Interventional Cardiac Device Manufactures

Description

India, China and Other Emerging MarketsIndia, China and Other Emerging Markets Key Prospects for Interventional Cardiac Device Manufactures PR Newswire MOUNTAIN VIEW, California, March 18, 2014 -- Frost & Sullivan: Manufacturers must expand capabilities and capacity through strategic partnerships in order to fulfill demand A high degree of unmet clinical needs, the rising prevalence of ailments such as coronary artery diseases and hypertension, as well as increasing disposable incomes are creating robust opportunities for emerging interventional cardiac devices in emerging countries. Although the U.S. and European markets will witness the highest growth, device manufacturers must focus on developing economies such as India and China, where the market is growing between 12 and 15 percent per annum. New analysis from Frost & Sullivan's analysis on The Global Emerging Interventional Cardiac Devices Market finds the market earned revenue of $1.49 billion in 2013 and estimates this to reach $6.93 billion in 2020. The analysis covers devices for the following segments: transcatheter heart valves, renal denervation, bronchial thermoplasty, bioresorbable stents, and fractional flow reserve. For complimentary access to more information on this research, please visit: http://bit.ly/1gvzpiG.

Subjects

• Documents
• Actualité et débat de société
• Media

Informations

• Published by: frost-sullivan
• Published: 18 March 2014
• Reads: 7
• Language: English

Exrait

India, China and Other Emerging Markets Key Prospects for Interventional Cardiac Device Manufactures

PR Newswire

MOUNTAIN VIEW, California, March 18, 2014

-- Frost & Sullivan: Manufacturers must expand capabilities and capacity through strategic partnerships in order to fulfill demand

A high degree of unmet clinical needs, the rising prevalence of ailments such as coronary artery diseases and hypertension, as well as increasing disposable incomes are creating robust opportunities for emerging interventional cardiac devices in emerging countries. Although the U.S. and European markets will witness the highest growth, device manufacturers must focus on developing economies such as India and China, where the market is growing between 12 and 15 percent per annum.